15 september 2015
15 september 2015

Announcement Maarten Frijlink as Company’s Chief Operating Office

Do you like it?
Read more
5 maart 2014
5 maart 2014

First Patient Enrolls in New Clinical Study of T-Guard® in the Treatment of GVHD

Do you like it?
Read more
13 januari 2014
13 januari 2014

Clinical study of T-Guard® in treatment of Graft vs Host Disease begins in The Netherlands

Do you like it?
Read more
Load more